Updates

Proactis

June 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Proactis supplies software that enables organisations to streamline, control and monitor all indirect expenditure. Since my last update, Proactis has ended bid talks. Having been impacted by the higher than usual customer attrition last year, it appears to be on the mend: in the context of £11.3m total contracts in FY19 (July year end), year to date wins have already reached that level with more than two months left to run. The banking facility has been reset with greater headroom. Finncap forecasts eps of 2p this year with 2.6p next. The broker notes PHD’s long-term contracts (£40.7m recurring revenue) and little short-term COVID-19 disruption, setting an 80p share price target. Speculative buy. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

AA - Lockdown sees batteries go flat; 27,000 sold last month

Billington

Proactis (October 2019)

Proactis (March 2019)

Proactis - 11.2p forecast for next year drops PE to 9.2 (September 2018)

Proactis (June 2018)

Proactis - Mouthwatering margins (March 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X